MA
Manisha Amod Tembhurnikar
About Manisha Amod Tembhurnikar
Data last updated:
Manisha Amod Tembhurnikar is a Designated Partner at Euten Pharma Llp (since 2020). The company operates in Business Services.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Euten Pharma Llp AAP-4044 | Designated Partner | 15 Dec 2020 | 2019 | Active |
Board colleagues of Manisha Amod Tembhurnikar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhaykumar Amarchand Chhallani | 08989774 | Euten Pharma Llp | Designated Partner |
| Brijbhushan Shriniwas Mahajan | 03539848 | Euten Pharma Llp | Designated Partner |
| Hardik Piyushkumar Agrawat | 00347694 | Euten Pharma Llp | Designated Partner |
| Mitesh Arjun Valvi | 08460631 | Euten Pharma Llp | Designated Partner |
| Rupali Rahul Gonjari | 08998532 | Euten Pharma Llp | Designated Partner |
| Tanuja Jeevak Ghadage | 08201706 | Euten Pharma Llp | Designated Partner |
| Yogesh Arun Suryawanshi | 08989799 | Euten Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manisha Amod Tembhurnikar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manisha Amod Tembhurnikar
Manisha Amod Tembhurnikar currently holds 1 directorship: Euten Pharma Llp (Designated Partner, since 15 Dec 2020).
Manisha Amod Tembhurnikar was first appointed on 15 Dec 2020 as Designated Partner at Euten Pharma Llp.
The current boards of Manisha Amod Tembhurnikar's companies include Abhaykumar Amarchand Chhallani (Euten Pharma Llp), Brijbhushan Shriniwas Mahajan (Euten Pharma Llp), Hardik Piyushkumar Agrawat (Euten Pharma Llp), Mitesh Arjun Valvi (Euten Pharma Llp), Rupali Rahul Gonjari (Euten Pharma Llp), Tanuja Jeevak Ghadage (Euten Pharma Llp), among others.